The World of Health & Medicine News

Neuralink plans ‘high-volume’ brain implant production by 2026, Musk says

Neuralink plans ‘high-volume’ brain implant production by 2026, Musk says

Elon Musk’s brain implant company Neuralink will start “high-volume production” of brain-computer interface devices and move to an entirely automated surgical procedure in 2026, Musk said in a post on the social media platform X on Wednesday.

The implant is designed to help people with conditions such as a spinal cord injury. The first patient has used it to play video games, browse the internet, post on social media, and move a cursor on a laptop.

The company began human trials of its brain implant in 2024 after addressing safety concerns raised by the U.S. Food and Drug Administration, which had initially rejected its application in 2022.

Neuralink said in September that 12 people worldwide with severe paralysis have received its brain implants and were using them to control digital and physical tools through thought. It also secured $650 million in a June funding round.

spot_img

Explore more

spot_img

Daewoong targets 100,000 beds, ₩300 bil. in digital health push with...

Daewoong targets 100,000 beds, ₩300 bil. in digital health push with AI monitoring platform Hospitals in Korea are quietly experimenting with a new way to...

US FDA proposes framework to speed rare disease gene therapy approvals

US FDA proposes framework to speed rare disease gene therapy approvals The U.S. Food and Drug Administration proposed on Monday a new framework to speed...

AstraZeneca’s fixed-duration Calquence combo wins FDA nod as BeOne CLL rivalry...

AstraZeneca's fixed-duration Calquence combo wins FDA nod as BeOne CLL rivalry heats up AstraZeneca has secured a key regulatory win in its effort to reclaim the lead...

WHO validates elimination of trachoma as a public health problem in...

WHO validates elimination of trachoma as a public health problem in Libya The World Health Organization (WHO) today announced that Libya has eliminated trachoma as...

US FDA approves Vanda’s antipsychotic pill

US FDA approves Vanda's antipsychotic pill The U.S. Food and Drug Administration has approved Vanda Pharmaceuticals' drug for the treatment of two serious mental health...

The 7 Common Causes Behind Tinnitus Ringing Ears

The 7 Common Causes Behind Tinnitus Ringing Ears Tinnitus affects nearly 50 million Americans, yet many people don't fully understand what causes it or how...

10 Health Benefits of Eating Dates

10 Health Benefits of Eating Dates There are many benefits to eating dates, including providing many nutrients and antioxidants, having anti-inflammatory and anti-tumor properties, promoting...

Combining GLP-1 drugs with hormones may lower uterine cancer risk

Combining GLP-1 drugs with hormones may lower uterine cancer risk Adding GLP-1 medications like Ozempic to progestin therapy could cut the risk of developing endometrial...